Ernexa Therapeutics Inc. (ERNA) Operating margin 2016–2025
Ernexa Therapeutics Inc. (ERNA) operating margin by fiscal year — reported operating income divided by reported revenue.
-1601.2%FY2025 · since FY2016: -9.3% → -1601.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1601.2% | +21448.8 pp |
| FY2024 | -23050.0% | — |
| FY2021 | -1960.9% | -1924.3 pp |
| FY2020 | -36.6% | -29.0 pp |
| FY2019 | -7.6% | -8.5 pp |
| FY2018 | 1.0% | +7.2 pp |
| FY2017 | -6.3% | +3.0 pp |
| FY2016 | -9.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ERNA financial trends
ERNA RevenueERNA Net incomeERNA Net marginERNA Gross profitERNA Gross marginERNA Operating incomeERNA Operating cash flowERNA Free cash flowERNA Capital expendituresERNA Return on equityERNA Stock buybacksERNA Dividends paidERNA Total assetsERNA Total liabilitiesERNA Shareholders’ equityERNA overview →